Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. (r)-3'-((2-((2-(3-chlorophenyl)-2-hydroxyethyl)amino)ethyl)amino)-(1,1'-biphenyl)-3-carboxylic Acid
2. 3'-((2-((2-(3-chlorophenyl)-2-hydroxyethyl)amino)ethyl)amino)-(1,1'-biphenyl)-3-carboxylic Acid
3. Gw 427353
4. Gw-427353
5. Gw427353
6. Solabegron Hydrochloride
1. 252920-94-8
2. (r)-3'-((2-((2-(3-chlorophenyl)-2-hydroxyethyl)amino)ethyl)amino)-[1,1'-biphenyl]-3-carboxylic Acid
3. Solabegron [inn]
4. Gw427353
5. 451470-34-1
6. Gw 427353
7. Gw-427353
8. 55p6yh9o6n
9. 3-[3-[2-[[(2r)-2-(3-chlorophenyl)-2-hydroxyethyl]amino]ethylamino]phenyl]benzoic Acid
10. [1,1'-biphenyl]-3-carboxylicacid,3'-[[2-[[(2r)-2-(3-chlorophenyl)-2-hydroxyethyl]amino]ethyl]amino]-
11. (1,1'-biphenyl)-3-carboxylic Acid, 3'-((2-(((2r)-2-(3-chlorophenyl)-2-hydroxyethyl)amino)ethyl)amino)-
12. (r)-3'-((2-((2-(3-chlorophenyl)-2-hydroxyethyl)amino)ethyl)amino)-(1,1'-biphenyl)-3-carboxylic Acid
13. Solabegronum
14. Unii-55p6yh9o6n
15. Solabegron-13c6
16. (r)-3'-[[2-[[2-(3-chlorophenyl)-2-hydroxyethyl]amino]ethyl]amino]-[1,1'-biphenyl]-3-carboxylic Acid
17. Solabegron [who-dd]
18. Chembl208427
19. Gtpl9512
20. Schembl2596555
21. Dtxsid50179932
22. Chebi:141346
23. Cka92094
24. Zinc1547346
25. Bdbm50002595
26. Db06190
27. Compound 38 [pmid: 16640337]
28. As-74724
29. Hy-19436
30. Cs-0015536
31. Gw 427353gw 427353
32. D93408
33. (r)-3'-(2-(2-(3-chlorophenyl)-2-hydroxyethylamino)ethylamino)biphenyl-3-carboxylic Acid
34. 3'-((2-(((2r)-2-(3-chlorophenyl)-2-hydroxyethyl)amino)ethyl)amino)biphenyl-3-carboxylic Acid
35. 3'-[(2-{[(2r)-2-(3-chlorophenyl)-2-hydroxyethyl]amino}ethyl)amino]-[1,1'-biphenyl]-3-carboxylic Acid
36. 3'-[(2-{[(2r)-2-(3-chlorophenyl)-2-hydroxyethyl]amino}ethyl)amino][biphenyl]-3-carboxylic Acid
| Molecular Weight | 410.9 g/mol |
|---|---|
| Molecular Formula | C23H23ClN2O3 |
| XLogP3 | 1.8 |
| Hydrogen Bond Donor Count | 4 |
| Hydrogen Bond Acceptor Count | 5 |
| Rotatable Bond Count | 9 |
| Exact Mass | 410.1397203 g/mol |
| Monoisotopic Mass | 410.1397203 g/mol |
| Topological Polar Surface Area | 81.6 Ų |
| Heavy Atom Count | 29 |
| Formal Charge | 0 |
| Complexity | 507 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Investigated for use/treatment in diabetes mellitus type 2, irritable bowel syndrome (IBS), and urinary incontinence.
Adrenergic beta-3 Receptor Agonists
Compounds that bind to and activate ADRENERGIC BETA-3 RECEPTORS. (See all compounds classified as Adrenergic beta-3 Receptor Agonists.)
Digital Content 
NEWS #PharmaBuzz
ABOUT THIS PAGE
14
PharmaCompass offers a list of Solabegron API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Solabegron manufacturer or Solabegron supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Solabegron manufacturer or Solabegron supplier.
PharmaCompass also assists you with knowing the Solabegron API Price utilized in the formulation of products. Solabegron API Price is not always fixed or binding as the Solabegron Price is obtained through a variety of data sources. The Solabegron Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Solabegron manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Solabegron, including repackagers and relabelers. The FDA regulates Solabegron manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Solabegron API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Solabegron supplier is an individual or a company that provides Solabegron active pharmaceutical ingredient (API) or Solabegron finished formulations upon request. The Solabegron suppliers may include Solabegron API manufacturers, exporters, distributors and traders.
Solabegron Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Solabegron GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Solabegron GMP manufacturer or Solabegron GMP API supplier for your needs.
A Solabegron CoA (Certificate of Analysis) is a formal document that attests to Solabegron's compliance with Solabegron specifications and serves as a tool for batch-level quality control.
Solabegron CoA mostly includes findings from lab analyses of a specific batch. For each Solabegron CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Solabegron may be tested according to a variety of international standards, such as European Pharmacopoeia (Solabegron EP), Solabegron JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Solabegron USP).
